{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04094090",
            "orgStudyIdInfo": {
                "id": "PXL-2211"
            },
            "organization": {
                "fullName": "Goodman Eye Center",
                "class": "OTHER"
            },
            "briefTitle": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
            "officialTitle": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-and-effectiveness-of-the-pxl-platinum-system-for-corneal-cross-linking-in-eyes-with-corneal-ectasia"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-10-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-19",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-19",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-09-13",
            "studyFirstSubmitQcDate": "2019-09-16",
            "studyFirstPostDateStruct": {
                "date": "2019-09-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-08-19",
            "lastUpdatePostDateStruct": {
                "date": "2022-08-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Goodman Eye Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.",
            "detailedDescription": "Patients with progressive keratoconus, pellucid marginal degeneration, or at risk for post-refractive corneal ectasia will be recruited and undergo epithelial-on corneal crosslinking with the Peschke PXL-330 system using pulsed, accelerated energy delivery. Patients will undergo monitoring for 1 year, with serial measurements of corneal topography, visual acuity, intraocular pressure, pachymetry, and visual function questionnaire."
        },
        "conditionsModule": {
            "conditions": [
                "Keratoconus",
                "Pellucid Marginal Corneal Degeneration",
                "Corneal Ectasia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "The study is a prospective, double-armed, randomized, single study.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pulsed, accelerated",
                    "type": "EXPERIMENTAL",
                    "description": "4 mW, 10-15 sec on, 10-15sec off, 45 minutes of illumination Intervention: Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution",
                    "interventionNames": [
                        "Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution"
                    ]
                },
                {
                    "label": "Pusled, accelerated",
                    "type": "EXPERIMENTAL",
                    "description": "8 mW, 10-15 sec on, 10-15 sec off, 22.5 minutes of illumination Intervention: Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution",
                    "interventionNames": [
                        "Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "PXL-330 Platinum device for crosslinking with Peschke riboflavin solution",
                    "description": "Riboflavin will be used to load the cornea, followed by UV-A crosslinking of the cornea",
                    "armGroupLabels": [
                        "Pulsed, accelerated",
                        "Pusled, accelerated"
                    ],
                    "otherNames": [
                        "Corneal crosslinking"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Best-contact corrected visual acuity (BSCVA)",
                    "description": "Change in BSCVA compared to baseline.",
                    "timeFrame": "3, 6, and 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Uncorrected visual acuity",
                    "description": "Change in UCVA compared to baseline.",
                    "timeFrame": "3, 6, and 12 months"
                },
                {
                    "measure": "Keratometry",
                    "description": "Change in Kmax, compared to baseline.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nSubjects who have one or both eyes that meet criteria 1 and 1 or more of the following criteria will be considered candidates for this study:\n\n1.10 years of age or older 2. Presence of central or inferior steepening 3. Axial topography consistent with keratoconus, post-surgical ectasia, or pellucid marginal degeneration 4. Presence of one or more findings associated with keratoconus or pellucid marginal degeneration, such as:\n\n1. Fleischer ring\n2. Vogt's striae\n3. Decentered corneal apex\n4. Munson's sign\n5. Apical Corneal scarring consistent with Bowman's breaks\n6. Scissoring of the retinoscopic reflex\n7. Crab-claw appearance on topography 5. Steepest keratometry (Kmax) value \u2265 47.20 D 6. I-S keratometry difference \\> 1.5 D on the Pentacam map or topography map 7. Posterior corneal elevation \\>16 microns 8. Thinnest corneal point \\>300 microns 9. Contact Lens Wearers Only:\n\na. Removal of contact lenses for the required period of time prior to the screening refraction: Contact Lens Type Minimum Discontinuation Time Soft or Scleral 3 days Rigid gas permeable 2 weeks\n\nExclusion Criteria:\n\nAll subjects meeting any of the following criteria will be excluded from this study:\n\n1. Eyes classified as either normal or atypical normal on the severity grading scheme.\n2. Corneal pachymetry at the screening exam that is \\<300 microns at the thinnest point in the eye(s) to be treated.\n3. Previous ocular condition (other than refractive error) in the eye(s) to be treated that may predispose the eye for future complications, for example:\n\n   1. History of or active corneal disease (e.g., herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, acanthomeoeba, etc.)\n   2. Clinically significant corneal scarring in the CXL treatment zone that is not related to keratoconus or, in the investigator's opinion, will interfere with the cross-linking procedure.\n4. Pregnancy (including plan to become pregnant) or lactation during the course of the study\n5. A known sensitivity to study medications\n6. Patients with nystagmus or any other condition that would prevent a steady gaze during the CXL treatment or other diagnostic tests.\n7. Patients with a current condition that, in the physician's opinion, would interfere with or prolong epithelial healing.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "10 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Goodman Eye Center",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel F Goodman, MD",
                            "role": "CONTACT",
                            "phone": "415-474-3333",
                            "email": "swong@goodmaneyecenter.com"
                        },
                        {
                            "name": "Daniel F Goodman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Individual participant data will be held in a secure location. While summary outcomes data will be provided on request to other researchers and periodically at scientific conferences, protected health information will not."
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "Prot",
                    "hasProtocol": true,
                    "hasSap": false,
                    "hasIcf": false,
                    "label": "Study Protocol",
                    "date": "2022-04-14",
                    "uploadDate": "2022-08-19T17:49",
                    "filename": "Prot_001.pdf",
                    "size": 786928
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007640",
                    "term": "Keratoconus"
                },
                {
                    "id": "D000003316",
                    "term": "Corneal Diseases"
                },
                {
                    "id": "D000004108",
                    "term": "Dilatation, Pathologic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10666",
                    "name": "Keratoconus",
                    "asFound": "Pellucid Marginal Corneal Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7292",
                    "name": "Dilatation, Pathologic",
                    "asFound": "Ectasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6539",
                    "name": "Corneal Diseases",
                    "asFound": "Corneal Ectasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "T4202",
                    "name": "Oculocerebral Syndrome With Hypopigmentation",
                    "relevance": "LOW"
                },
                {
                    "id": "T3218",
                    "name": "Keratoconus",
                    "asFound": "Keratoconus",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012256",
                    "term": "Riboflavin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014803",
                    "term": "Vitamin B Complex"
                },
                {
                    "id": "D000014815",
                    "term": "Vitamins"
                },
                {
                    "id": "D000018977",
                    "term": "Micronutrients"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000017319",
                    "term": "Photosensitizing Agents"
                },
                {
                    "id": "D000003879",
                    "term": "Dermatologic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M15085",
                    "name": "Riboflavin",
                    "asFound": "After treatment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M21009",
                    "name": "Micronutrients",
                    "relevance": "LOW"
                },
                {
                    "id": "M16885",
                    "name": "Trace Elements",
                    "relevance": "LOW"
                },
                {
                    "id": "M19608",
                    "name": "Photosensitizing Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7074",
                    "name": "Dermatologic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T463",
                    "name": "Riboflavin",
                    "asFound": "After treatment",
                    "relevance": "HIGH"
                },
                {
                    "id": "T470",
                    "name": "Vitamin B2",
                    "asFound": "After treatment",
                    "relevance": "HIGH"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}